StockWatch
·

Arvind SmartSpaces Ltd Q2 FY27 Results

ARVSMARTQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin expansion

Outlook: Cautiously Optimistic · Guidance: Raised

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue157.3650.5%12.0%
Total Income162.4349.6%12.8%
Expenditure130.0630.9%9.5%
PBT32.3775.8%28.0%
Net Profit22.7576.6%25.9%
OPM35.12%14.12pp14.11pp
NPM14.01%16.23pp1.47pp
EPS3.9382.0%27.2%
View full financials

Real estate revenue growth was modest at 12% YoY but OPM expanded sharply from 21% to 35%, driving a healthy 25.9% adjusted PAT growth — solid but not a sector standout given core top-line growth was unexceptional.

ARVIND SMARTSPACES · Q2 FY27 · THE VERDICT

The ₹863 Crore Gap: Can Arvind Convert Bookings Into Revenue?

Management upgraded bookings guidance to 70–75% growth (₹2,600–2,700 Cr), but H1 revealed a critical tension: ₹1,338 Cr in bookings yet only ₹475 Cr in revenue. The quarter tests whether launches convert as promised.

11 Nov 2026 · 6 min read
H1 Bookings

₹1,338 Cr

+120% YoY

H1 Revenue

₹475 Cr

+96% YoY

Bookings-revenue gap

₹863 Cr

2.8x ratio

Q2 Revenue

₹157.4 Cr

-50.5% QoQ

The headline reads like a blowout: H1 bookings surge 120% year-over-year, Arvind Sylva books ₹500+ crore in 30 days, management upgrades full-year guidance to 70–75% bookings growth. But dig into the revenue side and a different story emerges. H1 realized revenue was ₹475 crore—up 96% YoY but only 35.5% of the bookings generated in the same period. Q2 specifically seized ₹906 crore in new bookings yet delivered just ₹157.4 crore in revenue, a -50.5% sequential drop. The quarter forces a reckoning: are bookings the leading indicator of sustainable growth, or is the company accumulating future liabilities?

H1 FY27, ₹ Cr
0499.52999.041,498.561,338Bookings475Revenue754Collections
H1 bookings dwarf realized revenue, but collections remain robust. Bookings-to-revenue ratio of 2.8x suggests extended project cycles or inventory buildup.

Reconciling the gap

Management's defense: project cycle of 3–5 years. Presales (bookings) are advance indicators; revenue follows as projects move through construction and delivery. H1 collections of ₹754 crore (up 77% YoY) demonstrate cash generation is real. Q1 delivered an exceptional ₹318 crore in revenue from one large project; Q2 dropped to ₹157.4 crore, suggesting project mix volatility rather than execution failure. The core question: why does a bookings surge not carry forward into revenue? Sylva, Sarjapur, and the two upcoming MMR projects are still early in their collection phase. Revenue recognition typically lags booking by 12–36 months in real estate. But Q2's -50.5% sequential revenue decline despite accelerating bookings is not explained and raises concern that approvals or construction timelines may be stretching beyond stated norms.

Management's claims: what holds up

Grading the key assertions from the earnings call

FY27 bookings guidance revised to 70–75% growth (₹2,600–2,700 Cr)

Explicit revision: prior ₹2,100–2,200 Cr (35–40%) now ₹2,600–2,700 Cr (70–75%). Drivers: Sylva (₹500+ Cr), two MMR launches (₹2,200–2,500 Cr pipeline), Sarjapur (₹470 Cr estimated). Quantified and credible.

Supported

120% H1 bookings growth validates pricing power and market demand

H1 bookings ₹1,338 Cr (+120% YoY). Sylva booked ₹500+ Cr in 30 days at premium positioning. Market appetite is real, no contradiction.

Supported

Strong collections (₹754 Cr H1, +77% YoY) demonstrate cash generation

Collections ₹754 Cr H1 vs ₹425 Cr prior year (77% growth). Sustenance portfolio holds (~₹300 Cr H1); new project collections accelerating. Cash is genuine.

Supported

Normalized PAT margin is 22–25% EBITDA (implying 18–22% PAT)

Q2 delivered 14.4% PAT margin. H1 blended 25.3% due to Q1 exceptional project. Current tapering from Q1 (32.5% implied PAT) to Q2 (14.4%) is sharp. Guidance appears conservative or Q1 was a one-off.

Slightly overstated

Revenue conversion lag is expected; project cycle is 3–5 years

H1 gap of 2.8x is material. But Q2 -50.5% QoQ revenue despite bookings accelerating is unexplained and suggests project mix timing issues or collection delays beyond stated norms.

Partially contradicted

What changed on this call

Bookings guidance nearly doubled: Prior full-year FY27 guidance of 35–40% growth (₹2,100–2,200 Cr) upgraded to 70–75% (₹2,600–2,700 Cr). This reflects management's confidence in new launches. Regional rebalancing: Bengaluru now 50% of H1 sales (up from 30% prior year), driven by Sylva. MMR now a core third market with two projects in approval-to-launch phase. Project pipeline visibility: Sylva (₹500+ Cr booked immediately), Sarjapur (₹470 Cr estimated GDV), two MMR launches (₹2,200–2,500 Cr pipeline). Most concrete forward pipeline disclosed to date. Capex acceleration: Business development spend doubled; BD locked at ₹3,100 Cr (Sep 2026), targeting ₹4,000–5,000 Cr by FY27-end. Construction capex also doubled, but management avoided specifying absolute numbers. This opacity raised analyst concerns on leverage trajectory. The critical new concern: Sequential revenue decline. Q2 revenue at ₹157.4 Cr is -50.5% from Q1's ₹318 Cr, despite bookings accelerating. This cliff is not explained and suggests project mix volatility or timing uncertainty.

The bull-bear ledger
  • 120% H1 bookings growth; Sylva ₹500 Cr in 30 days validates premium positioning

  • Strong collections (₹754 Cr H1, +77% YoY); cash generation is real

  • Multi-city footprint (Ahmedabad, Bengaluru, MMR) diversifies revenue risk

  • 25% IRR hurdle discipline and 70–30 JD-to-outright split show capital discipline

  • FY27 bookings guidance quantified and credible (₹2,600–2,700 Cr)

  • 2.8x bookings-revenue gap in H1; presales not converting at expected pace

  • Q2 revenue -50.5% QoQ despite bookings accelerating; conversion gap widens

  • Customer concentration: Sylva ₹500 Cr + Sarjapur ₹470 Cr = ~₹1,000 Cr lumpy pipeline

  • Capex doubling with no absolute numbers disclosed; leverage trajectory opaque

  • Margin guidance 22–25% EBITDA vs. current 41.5% H1; implies 19.5pp compression

  • Management deflecting on specifics (capex, exact margin timeline)

Risks, ranked by severity for a holder

Revenue conversion lag persists or widens

High

H1 bookings-to-revenue ratio of 2.8x is material. If Q3/Q4 conversion ratio doesn't improve, presales could accumulate as unfulfilled liabilities, forcing guidance miss and margin compression.

Project execution slips (Sylva, Sarjapur, MMR concurrent launches)

High

Four major concurrent projects in design-to-launch. Any delay in approval (7–9 month cycle) or construction impacts presales and revenue recognition. Concentration on few projects means one slip = material impact.

Customer concentration: Sylva and Sarjapur dominate pipeline

Medium

Sylva (₹500+ Cr booked, ~60% of Bengaluru by value) and Sarjapur (₹470 Cr estimated) represent ~₹1,000 Cr of H2 FY27 / H1 FY28 pipeline. Underperformance in either project would materially pressure full-year targets.

Margin compression vs. guidance: 22–25% EBITDA implies 19.5pp contraction from current H1

Medium

Current H1 EBITDA margin 41.5%, guided 22–25%. Q2 actual 14.4% PAT margin. If realized margins stabilize at 14–16% PAT, FY27 earnings growth will disappoint despite bookings surge.

Leverage tightens if capex accelerates and bookings conversion slows

Medium

Debt/equity 0.26 appears safe, but BD spend doubling to ₹4,000–5,000 Cr annual run-rate + construction capex 'doubled' could tighten leverage if presales-to-collections conversion lags.

How the street is positioned

Price action and technicals: Stock closed at ₹605 (November 9, 2026). Up 24.28% from the 52-week low (₹486.8) but down 40.98% from its all-time high (₹1,025). Trading above SMA20 (₹592.35), SMA50 (₹602.48), and SMA200 (₹590.46)—all bullish. RSI at 53.3 is neutral—neither overbought nor oversold. The stock is in a bull market but well off its peak; the drawdown reflects market skepticism on execution despite upside guidance.

Institutional positioning: FII ownership eroded from 1.60% (Q1 FY25) to 0.69% (Q1 FY27)—a concerning 91 basis point drain despite upside bookings guidance. DII ownership steady at ~8–9% most recent quarters. Promoter ownership stable at 53.8%. The FII trim is a red flag: foreign institutions are reducing exposure into bullish fundamentals, suggesting skepticism on execution risk. This contrarian signal (institutions selling into upside) warrants attention.

Bulk and block activity: Recent bulk deals (Aug–Sep 2026) show tactical trading: MICROCURVES, QE SECURITIES, and NK SECURITIES alternating buys/sells in the ₹645–665 band. No smoking gun (no obvious insider selling near highs, no promoter trim). Activity suggests professional traders are hedging exposure rather than making a binary bet.

Reconciling market vs. fundamental reads: The market is pricing in significant upside (70–75% bookings growth, multi-city expansion, ₹500 Cr launches) but applying an execution discount. Stock down 41% from ATH, FII trim despite bullish guidance, yet technicals bullish above all SMAs—this is the market saying: 'We believe the upside story, but we don't trust execution yet.' Conviction will return when Q3 revenue shows conversion acceleration or when a major project (Sarjapur, MMR) de-risks execution.

What to watch next
  • 1 · Q3 FY27 revenue and conversion ratio

    Is the bookings-to-revenue lag narrowing or widening? Collections as a % of bookings is the key metric. If Q3 revenue accelerates (target: sequential growth or YoY >20%), execution risk narrative cracks. If stalls or declines, the 2.8x gap becomes the story.

  • 2 · Sarjapur and MMR project launches and early traction

    Sylva succeeded brilliantly (₹500 Cr in 30 days). Do Sarjapur (₹470 Cr estimated) and two MMR projects (₹2,200–2,500 Cr combined) validate multi-city strategy, or reveal concentration to Bengaluru/Sylva as a fluke? Early booking velocity determines whether ₹2,600–2,700 Cr FY27 guidance is achievable.

  • 3 · FY27 capex and leverage trajectory

    Management must quantify absolute construction capex and debt roadmap. Doubling BD spend + construction capex doubling with no absolute numbers is unacceptable for equity holders. Clarity by end of FY27 would restore credibility.

Arvind SmartSpaces is executing steady multi-city expansion with real upside, not a step-change transformation. The bookings story (120% YoY H1, 70–75% FY27 guidance, ₹500 Cr launches) is credible. But the revenue conversion lag (2.8x gap, Q2 -50.5% QoQ) creates material execution risk. Management has proven it can book business; now it must prove it can convert that business into revenue and margin on stated timelines. Confidence is encouraging; deflecting on capex and margin specifics in a high-leverage ramp-up is cautionary. The street's positioning (FII trim into upside guidance, stock down 41% from ATH, technicals bullish) mirrors this skepticism: upside is priced in, credibility is not yet earned. Track Q3 conversion ratio (collections/bookings) and Q3 revenue YoY growth; acceleration signals execution risk is abating. Until then, the honest rating is Hold—conviction must be earned on the numbers, not assumed on the story.

Informational and educational content only. Not investment advice.